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red pulp of human spleen. B cells in human bone marrow 
highly expressed CD37, whereas the expression of CD53 
was low. In conclusion, we demonstrate differential expres-
sion of CD37 and CD53 on primary human immune cells, 
their subcellular localization and their quantitative distribu-
tion in human lymphoid organs. This study provides a solid 
basis for better insight into the function of tetraspanins in 
the human immune response.
Keywords Multispectral imaging · Tetraspanin · CD37 · 
CD53 · Immune system
Introduction
The specific cellular architecture of primary and secondary 
lymphoid organs aids in the complex coordination of the 
initiation of the immune response against a wide variety of 
pathogens and tumor cells. The microarchitecture of lym-
phoid organs is highly dynamic, and its structure changes 
constantly upon antigen encountering. Whereas primary 
lymphoid organs (bone marrow, thymus) are the major 
sites of lymphocyte development, secondary lymphoid 
organs (spleen, lymph nodes and mucosal-associated lym-
phoid tissues, like appendix) provide a sophisticated envi-
ronment in which immune cells interact with each other, 
as well as with accessory cells and antigens. Secondary 
lymphoid organs have a remarkably similar microanatomy 
under homeostatic conditions in which essentially three dif-
ferent regions can be distinguished (Junt et al. 2008). The 
outermost region is the antigen-sampling region where 
antigen-presenting cells, including macrophages and den-
dritic cells (DCs), sample and deliver antigens to the B 
and T cell areas. The outer cortex contains predominantly 
B cell follicles where germinal centers (GCs) can develop 
Abstract Multispectral imaging is a novel microscopy 
technique that combines imaging with spectroscopy to 
obtain both quantitative expression data and tissue distribu-
tion of different cellular markers. Tetraspanins CD37 and 
CD53 are four-transmembrane proteins involved in cellu-
lar and humoral immune responses. However, comprehen-
sive immunohistochemical analyses of CD37 and CD53 in 
human lymphoid organs have not been performed so far. 
We investigated CD37 and CD53 protein expression on pri-
mary human immune cell subsets in blood and in primary 
and secondary lymphoid organs. Both tetraspanins were 
prominently expressed on antigen-presenting cells, with 
highest expression of CD37 on B lymphocytes. Analysis of 
subcellular distribution showed presence of both tetraspa-
nins on the plasma membrane and on endosomes. In addi-
tion, CD53 was also present on lysosomes. Quantitative 
analysis of expression and localization of CD37 and CD53 
on lymphocytes within lymphoid tissues by multispectral 
imaging revealed high expression of both tetraspanins on 
CD20+ cells in B cell follicles in human spleen and appen-
dix. CD3+ T cells within splenic T cell zones expressed 
lower levels of CD37 and CD53 compared to T cells in the 
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and the inner cortex comprises mainly T cells. A special-
ized conduit system, formed by interconnected fibroblastic 
reticular cells, supports migration of DCs and lymphocytes 
through different areas of the lymphoid organs to interact 
with other immune cells. In addition, this system provides 
a tubular network for distribution of small soluble antigens 
and immune modulators enabling communication between 
the antigen-sampling zone and the T cell zone (Roozendaal 
et al. 2008).
Cell–cell communication and immune cell migration are 
controlled by a wide variety of different immunoreceptors 
embedded in the plasma membrane. These immunorecep-
tors are non-randomly distributed in the plasma membrane 
by means of specialized membrane domains (Zuidscher-
woude et al. 2014). This compartmentalization is essential 
for immune cell function, including pathogen recognition, 
antigen presentation and migration. Tetraspanin-enriched 
microdomains (TEM) are functional multimolecular com-
plexes in the plasma membrane (Rubinstein et al. 1996; 
Hemler 2005; Yanez-Mo et al. 2009; Charrin et al. 2014) 
in which tetraspanins interact with each other and with 
partner molecules, like transmembrane immunorecep-
tors, enzymes and signaling proteins. Tetraspanin proteins 
belong to the superfamily of four-transmembrane proteins 
that are expressed at the cell surface and in intracellular 
membranes. To date, 33 different tetraspanins have been 
characterized in humans of which tetraspanins CD37 and 
CD53 are specific for the immune system (Hemler 2005). 
Tetraspanin CD37 has been studied extensively in CD37-
deficient (Cd37−/−) mice in which both the cellular and 
humoral arms of the immune system are defective. CD37 
inhibits T cell proliferation (van Spriel et al. 2004), inter-
leukin-6 production by macrophages (Meyer-Wentrup et al. 
2007) and antigen presentation by DCs (Sheng et al. 2009). 
Moreover, CD37 tightly regulates antibody production 
by B cells (van Spriel et al. 2012). Cd37−/− mice have a 
strikingly increased number of IgA+ plasma cells in their 
lymphoid organs, whereas the number of IgG+ plasma 
cells is low due to decreased survival signals in the GCs 
of the spleen (van Spriel et al. 2009, 2012). The function 
of tetraspanin CD53 has not been well studied although 
recurrent infections have been reported in a CD53-deficient 
family (Mollinedo et al. 1997). The underlying mechanism 
of tetraspanin function has been attributed to specific inter-
actions between tetraspanins and immunoreceptors [major 
histocompatibility complex (MHC) proteins, B cell recep-
tor (BCR), integrins and others] in the plasma membrane.
Despite the importance of tetraspanins in the immune 
system, little is known about their expression and micro-
anatomical location. In this study, tetraspanins CD37 and 
CD53 were selected as these are among all tetraspanins 
exclusively present in the immune system. We report their 
membrane and intracellular expression on primary human 
blood immune cell subsets. Furthermore, we performed 
detailed quantitative immunohistochemical analyses using 
multispectral imaging to reveal tetraspanin expression and 
localization in human primary and secondary lymphoid 
organs. This novel technique allows for a direct unbiased 
overview of different tissues with the main advantage that, 
next to information on the single-cell expression level, the 
differential tissue localization of individual cell subsets can 
be studied.
Materials and methods
Cells
Cells were obtained from buffy coats of healthy individuals 
with informed consent in accordance with institutional and 
international guidelines following the Declaration of Hel-
sinki. Peripheral blood mononuclear cells (PBMCs) were 
obtained by Ficoll density centrifugation. PBMCs were 
cultured in RPMI-1640 supplemented with 2 % human 
serum (HS) in Costar culture flasks (1 × 108 cells/75 cm2 
flask) to adhere monocytes for 1 h at 37 °C. After removal 
of peripheral blood lymphocytes (PBLs), monocytes were 
harvested with cold PBS.
Flow cytometry
Single-cell suspensions were first stained with primary 
antibodies against human CD53 (mem53, Serotec), CD37 
(WR17, home-made) or isotype controls in PBS with 1 % 
BSA and 0.05 % NaN3 (PBA) supplemented with 2 % HS 
for 30 min at 4 °C, followed by incubation with goat-anti-
mouse Alexa488 antibody (Molecular Probes). Next, cells 
were stained with the following anti-human antibodies: 
CD3-PE (HIT3a, Becton–Dickinson), CD4-APC (RPA-
T4, Biolegend), CD8-PerCP (SK1, Becton–Dickinson), 
CD20-APC (2H7, eBioscience), CD14-PE (CLB-mon/1, 
Pelicluster, Sanquin), CD56-APC (NCAM16.2, Bec-
ton–Dickinson), CD19-PerCP (4G7, Becton–Dickinson), 
BDCA1-FITC (AD5-8E7, Miltenyi) and/or BDCA2-FITC 
(AC144, Miltenyi). Stained cells were analyzed using 
FACS Calibur (Becton–Dickinson) and FlowJo software 
(version 9.7, TreeStar Inc.).
Confocal microscopy
Fibronectin-coated coverslips were made by incubation 
of 20 μg/mL fibronectin (Roche) in PBS for 1 h at 37 °C. 
Monocytes were adhered on fibronectin-coated coverslips 
for 2 h and subsequently fixed with 2 % paraformaldehyde 
(PFA) and blocked with 3 % bovine serum albumin (BSA), 
1 % HS and 10 mM glycine in PBS for 30 min at room 
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temperature (RT). Cells were permeabilized and stained 
with antibodies against CD53 (mem53, Serotec), CD37 
(WR17, home-made), calreticulin (ER marker, Sigma), syn-
taxin 12/13 [endosome marker, Synaptic Systems (cat. no. 
110132)] and Lamp1 (lysosome marker, Sigma-Aldrich) in 
0.5 % saponin, 1 % BSA, 10 mM glycine, 1 % HS in PBS, 
followed by goat-anti-mouse Alexa488 and goat-anti-rabbit 
Alexa647 (Molecular Probes). Samples were imaged with 
an Olympus FV1000 confocal laser scanning microscope. 
Images were analyzed using Fiji software (Schindelin et al. 
2012).
Tissues
Human spleen samples were obtained from deceased 
human kidney donors and bone marrow, and appendix 
samples were obtained from healthy donors, which were 
approved by the Medical Ethical Committee for Human 
Research (Radboudumc, The Netherlands). All tissue sam-
ples were formalin-fixed, paraffin-embedded and cut in 
4 μm sections according to standard procedures (Canene-
Adams 2013).
Immunofluorescence
Tissues were deparaffinized, followed by antigen retrieval 
using 10 mM citrate buffer and blocked with 10 % normal 
goat serum (NGS) in PBA for 1 h at RT. Tissues were first 
stained with antibodies against human CD37 (clone 2B8, 
Thermo Scientific) or CD53 (clone EPR4342(2), GenTex) 
diluted in 2 % NGS in PBA for 1 h at RT, followed by incu-
bation with Alexa-conjugated secondary antibodies diluted 
in 1 % NGS in PBA for 1 h at RT. For nuclear staining, tis-
sues were incubated for 5 min with DAPI (diluted 1:3000 
in PBS). Tissue slides were fixed in 1 % PFA in PBS for 
15 min at RT and embedded in Mowiol mounting medium.
Immunohistochemistry
Tissues were deparaffinized, followed by antigen retrieval 
using 10 mM citrate buffer and blocked with 3 % hydro-
gen peroxidase (H2O2) in methanol for 10 min at RT. Tis-
sues were blocked with 2 % HS in Tris-buffered saline 
(TBS) with 1 % BSA for 45 min at RT and stained with 
primary antibodies against human CD3 (clone CD3-12, 
AbD Serotec) or CD20 (clone L26, Thermo Scientific) 
diluted in TBS supplemented with 1 % BSA overnight at 
4 °C. Next, tissues were incubated with biotinylated sec-
ondary antibodies diluted in TBS with 1 % BSA, 1 % HS 
and 1 % NGS or normal horse serum (NHS) for 45 min at 
RT. After 1 h incubation with avidin–biotin alkaline phos-
phatase complex (ABC-AP) solution, red color was devel-
oped by incubation with Warp Red Solution for 10 min. 
Secondly, tissues were stained with antibodies against 
human CD37 (clone 2B8, Thermo Scientific) or CD53 
(clone EPR4342(2), GenTex) diluted in PBS, 1 % BSA, 
2 % HS for 45 min at RT, followed by incubation with 
biotinylated secondary antibodies in TBS with 1 % BSA, 
1 % HS and 1 % NHS or NGS for 45 min at RT. After 
1 h incubation with avidin–biotin horseradish peroxidase 
complex (ABC-HRP) solution, blue color was developed 
by incubation with True Blue peroxidase substrate for 
8 min. For technical reasons, CD20 and CD37 could not 
be stained on the same slide, as such single staining for 
CD37 was performed. For nuclear staining, tissues were 
incubated for 1 min with Nuclear Red. Dried sections were 
embedded in Permount.
Multispectral imaging and quantitative digital analysis
Tissue slides were imaged using Vectra Intelligent Slide 
Analysis System (version 2.0.8, PerkinElmer Inc.). This 
imaging technique combines imaging with spectroscopy 
where the entire spectrum is collected at every location 
of the image plane in an automatic manner. Images of 
single-stained tissues for each fluorophore or chromogen, 
with its own unique spectral characteristics, were used to 
built spectral libraries with Nuance Multispectral Imaging 
System (version 3.0.2, PerkinElmer Inc.). For correction 
of autofluorescence, an image was made from unstained 
human spleen tissue and the autofluorescence signal was 
subtracted from the spectrum for each fluorophore. These 
spectral libraries were used to unmix the original multi-
spectral images obtained with the Vectra imaging system. 
Two red chromogens (Warp Red and Nuclear Red) with 
highly similar spectra were used of which correct unmixing 
has been described before (Van Der Loos 2010). A selec-
tion of ten representative original multispectral images 
was used to train the inForm Advanced Image Analysis 
Software (version 2.0.2, PerkinElmer Inc.) for quantitative 
image analysis (tissue and cell segmentation, quantification 
of the expression levels of proteins of interest) as described 
before (Mansfield 2010; Stack et al. 2014). The threshold 
for dim or bright tetraspanin expression was determined 
by objective examination of the staining intensity of non-
immune cells in True Blue-negative regions. All the set-
tings applied to the training images were saved within an 
algorithm allowing batch analysis of multiple original mul-
tispectral images of different samples of the same origin 
equally stained. The number of images used for quantifica-
tion and statistical analysis of CD37 and CD53 distribution 
was dependent on the acquisition of the tissue slides during 
imaging (i.e., the position of the tissue on the coverslip can 
vary, leading to acquisition of less or more images). If 20× 
images contained less than 10 % of tissue, these images 
were discarded from the analysis. Since not all 20× images 
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contained B cell follicles or T cell regions, a higher num-
ber of images were analyzed for red pulp or lamina propria 
regions (Supplementary Table 1).
Statistics
Statistical differences of tetraspanin expression between 
different tissue regions in human lymphoid organs were 
determined using the unpaired Student’s t test or, in case 
of a non-Gaussian distribution, the Mann–Whitney test 
(GraphPad Prism 5, GraphPad Software, San Diego, CA, 
USA). All differences with P ≤ 0.05 were considered to be 
statistically significant.
Results
Expression of CD37 and CD53 on immune cell subsets 
in blood
To investigate cell surface expression of tetraspanins CD37 
and CD53 on the plasma membrane of different immune 
cell subsets in blood, PBLs were stained for CD4 (T cells), 
CD8/CD3/CD56− (T cells), CD20 (B cells), CD14 (mono-
cytes), CD56/CD3−/CD8− (NK cells) and BDCA1/
CD19− (myeloid DC (mDC)) and BDCA2 (plasmacytoid 
DC (pDC)) (Supplementary Fig. 1). We observed the high-
est CD37 expression on B cells and low to medium expres-
sion on T cells, monocytes and NK cells (Fig. 1a, b). CD53 
was expressed on all subsets, with highest expression on 
B cells and monocytes (Fig. 1a, c). CD37 and CD53 were 
expressed on both mDCs and pDCs, with no apparent dif-
ferences in expression level between the two DC subsets 
(Fig. 1d–f). It has been reported that tetraspanins can be 
expressed at intracellular membranes (Kobayashi et al. 
2000; Xu et al. 2009), which stimulated us to investigate 
the subcellular localization of CD37 and CD53. Mono-
cytes were double stained with CD37 or CD53 antibodies 
in combination with antibodies specific for the endoplas-
matic reticulum (ER), endosomes or lysosomes. Next to the 
expression on the plasma membrane, both CD37 and CD53 
were abundantly expressed in the endosomes, in contrast 
to the ER (Fig. 2a, b). In the lysosomes, we observed only 
CD53 to be present.
Multispectral analyses of human lymphoid organs
We investigated the tissue distribution of CD37 and CD53 
in human lymphoid organs by multispectral imaging. In 
contrast to classical immunohistochemistry, multispectral 
imaging directly provides quantitative information into the 
differential tissue distribution of individual cell subsets. 
First, we investigated localization of CD37 and CD53 in 
human spleen. We observed that CD37 was more locally 
expressed in follicle-like structures when compared to 
CD53 which showed a more dispersed expression profile 
(Fig. 3a–e). To explore this in more detail, we performed 
double staining of either the T cell marker CD3 or the B 
cell marker CD20 combined with CD37 or CD53 on pri-
mary (bone marrow) and secondary (spleen and appen-
dix) lymphoid tissues. Figure 4 illustrates the technology 
of multispectral imaging and analysis of lymphoid tis-
sue stained for the B cell marker CD20 (Warp Red), tet-
raspanin CD53 (True Blue) and cell nuclei (Nuclear Red). 
Single-stained tissues for each chromogen (Warp Red, 
True Blue and Nuclear Red) were used to create a spectral 
library containing the specific spectra of each used chromo-
gen (Fig. 4a) allowing to unmix the original multispectral 
images (Fig. 4b). This resulted in separate images for each 
marker (Fig. 4d–f) that were used to generate the composite 
RGB image (Fig. 4c). We made use of two red chromogens 
(Warp Red and Nuclear Red) with highly similar spectra of 
which correct unmixing has been described before (Van Der 
Loos 2010). Next, analysis software was trained using ten 
representative original multispectral images to segment the 
different tissue regions (B cell follicle and stromal tissue 
(red pulp in spleen or lamina propria in appendix)) based 
on a combination of parameters including cell morphology 
and specific staining (Fig. 4g) and individual cells based on 
nuclear characteristics (Fig. 4h). For each cell, CD20 posi-
tivity and CD53 expression were determined in relation to 
tissue localization (Fig. 4i–l). These settings were saved 
within an algorithm allowing batch analysis of multiple 
original multispectral images of the same tissue and stain-
ings. Figure 5 shows similar analysis for lymphoid tissue 
stained for the T cell marker CD3 (Warp Red), tetraspanin 
CD37 (True Blue) and cell nuclei (Nuclear Red). Origi-
nal multispectral images were unmixed using the spectral 
library showed in Fig. 4a (Fig. 5a–e). Next, tissue segmen-
tation was performed for T cell zones, B cell follicles and 
red pulp regions (Fig. 5f), followed by cell segmentation 
(Fig. 5g) and analysis of CD3 and CD37 expression within 
the different tissue regions (Fig. 5h–l). As expected, B cell 
follicles mainly consisted of CD20-positive cells, and T 
Fig. 1  Expression of CD37 and CD53 on immune cell subsets in 
blood. a Flow cytometry analysis of expression of CD37 or CD53 
(black line) on CD4 and CD8 T cells, B cells, monocytes and NK 
cells versus isotype control (gray line). Gating strategy is presented 
in Supplementary Figure 1. Expression levels of CD37 (b) and CD53 
(c) were normalized for isotype staining by background subtraction. 
Experiments were performed with PBLs from three healthy donors. 
Data present mean ± SD. d Flow cytometry analysis of expression 
of CD37 or CD53 (black line) on mDCs (BDCA1+CD19−) or pDCs 
(BDCA2+) versus isotype control (gray line). Expression levels of 
CD37 (e) and CD53 (f) were normalized for isotype staining by back-
ground subtraction. Experiments were performed with PBLs from 
two healthy donors. Data present mean ± SD
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cell zones contained mainly CD3-positive cells. The stro-
mal tissue consisted of both CD20- or CD3-negative and 
CD20- or CD3-positive cells. Altogether, we established 
multispectral imaging analysis to combine quantitative tet-
raspanin expression data with specific tissue localization in 
human lymphoid tissues.
Localization and quantitative expression of CD37 
and CD53 in lymphoid organs
We studied the localization and expression of tetraspanin 
CD37 in primary and secondary lymphoid organs. Since 
bone marrow does not contain different T and B cell areas, 
ER
Endosome
Lysosome
CD37 Merged TM
ER
Endosome
Lysosome
CD53 Merged TM
(a)
(b)
Fig. 2  Subcellular localization of CD37 and CD53. Localization of a CD37 or b CD53 (green) in monocytes was studied by dual staining with 
calreticulin (ER), syntaxin 13 (endosomes) or Lamp1 (lysosomes) (red). Merge: co-localization in yellow (white arrows). Scale bar 5 μm
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tissue segmentation was not applicable and only cell seg-
mentation was performed (Figs. 6a–c, 7a–c). The intensity 
[optical density (OD)] of CD37 in bone marrow ranged 
from 0.05 to 0.85, with a mean of 0.29 (ODmean; Fig. 6d). 
We observed around 80 % of all bone marrow cells to be 
CD37bright (Fig. 6e) and 90 % of all T cells to be highly 
positive for CD37 (Fig. 6f). The scatter plots with the set 
thresholds to annotate cells with dim and bright expres-
sion of CD37 and CD53 are shown in Figs. 4j–l, 5i–l and 
Supplementary Figures 2 and 3. In human spleen, B cell 
follicles, T cell zones and red pulp areas were efficiently 
distinguished (Figs. 6g–i, 7g–i). CD37 showed highest 
expression in the B cell follicles (ODmean = 0.22) compared 
to the T cell zones and red pulp areas (ODmean = 0.15; 
Fig. 6j). In splenic B cell follicles, twice as many cells were 
CD37bright, compared to the red pulp where only 45 % of 
the cells was CD37bright (Fig. 6k). When focusing on CD37 
expression on splenic T cells, we observed that significantly 
more T cells were CD37bright in the red pulp as compared 
to T cells in T cell zones (Fig. 6l). In the appendix, B cell 
follicles and lamina propria regions were located immedi-
ately below the crypts (Figs. 6m–o, 7m–o). CD37 showed 
highest expression in B cell follicles (ODmean = 0.12) com-
pared to the lamina propria (ODmean = 0.09) in appendix 
(Fig. 6p) which is in line with CD37 expression in spleen. 
In the B cell follicles in human appendix, almost all cells 
were CD37bright, which was significantly more than in the 
lamina propria where around 80 % of total cells expressed 
high levels of CD37 (Fig. 6q). Similar to the red pulp in 
spleen, significantly more T cells in the lamina propria 
(b) Composite(a) Original
(c) CD37 (d) CD53
(e) DAPI
Fig. 3  Expression of CD37 and CD53 on human spleen. a Original 
multispectral image of human spleen stained for CD37 (Alexa488), 
CD53 (Alexa568) and cell nuclei (DAPI). Scale bar 100 μm. Com-
posite RGB image (b) of unmixed CD37 (c in green), CD53 (d in 
red) and DAPI (e in blue) signal after correction for autofluorescence. 
One representative image is shown
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Fig. 4  Spectral imaging analysis of human spleen stained for CD20 
(Warp Red), CD53 (True Blue) and cell nuclei (Nuclear Red). a A 
spectral library of three chromogens (Warp Red (red line), True Blue 
(blue line) and Nuclear Red (green line)) was built in Nuance soft-
ware using single-stained human spleen tissues. b Representative 
original multispectral image. Scale bar 100 μm. Composite RGB 
image (c) of unmixed CD20 (d in red), CD53 (e in blue) and nuclei 
(f in green in composite RGB image) signal. g Tissue segmenta-
tion; B cell follicle (B, yellow), red pulp (RP, green) and other tis-
sue (blood vessels, collagen; blue). h Segmentation of individual 
cells (green) based on Nuclear Red staining. i Thresholds for Warp 
Red and True Blue staining were set to score CD20−CD53dim (blue), 
CD20+CD53dim (red), CD20+CD53bright (yellow) or CD20−CD53bright 
(green) cells. j–l Scatter plots showing optical densities for CD20 
(Y-axis) and CD53 (X-axis) of individual cells in B cell follicles (j, 
l blue) and red pulp (k–l red) and thresholds used for scoring (dotted 
lines). A representative of 2000 cells per tissue region is plotted
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Fig. 5  Spectral imaging analysis of human spleen stained for CD3 
(Warp Red), CD37 (True Blue) and cell nuclei (Nuclear Red). a 
Representative original multispectral image. Scale bar = 100 μm. 
Composite RGB image (b) of unmixed CD3 (c in red), CD37 (d in 
blue) and Nuclear Red (e in green in composite RGB image) signal 
using the spectral library (Fig. 4a). f Tissue segmentation; B cell fol-
licle (B, yellow), T cell zone (T, red), red pulp (RP, green) and other 
tissue (blood vessels, collagen; blue). g Segmentation of individual 
cells (green) based on Nuclear Red staining. h Thresholds for Warp 
Red and True Blue staining were set to score CD3−CD37dim (blue), 
CD3+CD37dim (red), CD3+CD37bright (yellow) or CD3−CD37bright 
(green) cells. i–l Scatter plots showing optical densities for CD3 
(Y-axis) and CD37 (X-axis) of individual cells in T cell zones (i, l 
green), B cell follicles (j, l blue) and red pulp regions (k–l red) and 
thresholds used for scoring (dotted lines). A representative of 2000 
cells per tissue region is plotted
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were CD37bright compared to the T cells within B cell folli-
cles of the appendix (Fig. 6r). However, we need to be care-
ful with interpreting these data, because the frequency of T 
cells in the appendix is very low.
Next, we performed multispectral imaging analy-
ses for tetraspanin CD53 in human bone marrow, spleen 
and appendix. In bone marrow, the OD of CD53 ranged 
between 0.05 and 0.60, with an ODmean of 0.13 (Fig. 7d). 
The CD20+ B cells in bone marrow were mostly CD53dim 
(Fig. 7e), contrary to the majority of CD3+ T cells that 
were CD53bright (Fig. 7f). In human spleen, we observed 
CD53 to be expressed at higher levels in B cell follicles 
(ODmean = 0.15) than in the red pulp and T cell zones 
(ODmean = 0.09; Fig. 7j). In contrast to human bone 
marrow, almost 100 % of CD20+ B cells in the spleen 
were CD53bright, significantly more than in the splenic 
red pulp where 85 % of B cells expressed high levels 
of CD53 (Fig. 7k). Similar to CD37 expression, sig-
nificantly more T cells in the red pulp compared to the 
T cell zone were CD53bright (Fig. 7l). In human appen-
dix, CD53 was slightly higher expressed in B cell folli-
cles (ODmean = 0.10) than in the lamina propria regions 
(ODmean = 0.07; Fig. 7p). B cells within B cell follicles 
and lamina propria expressed similar levels of CD53 
(Fig. 7q), whereas significantly more T cells in the B cell 
follicle expressed high levels of CD53 compared to T 
cells in the lamina propria (Fig. 7r). Together, these data 
demonstrate that CD37 and CD53 are differentially local-
ized and expressed in human bone marrow and in B cell, 
T cell and red pulp or lamina propria regions in human 
spleen and appendix. Furthermore, B and T cells have dif-
ferent expression levels of tetraspanin proteins depending 
on their localization within the tissue.
Discussion
Here, we provide the quantitative expression of tetraspanins 
directly linked to tissue distribution in human lymphoid 
organs using multispectral imaging. Tetraspanin proteins 
are important in controlling cellular immune responses 
which is evidenced by the defects in the immune system of 
different tetraspanin-deficient mice (Knobeloch et al. 2000; 
Takeda et al. 2008; Sheng et al. 2009; Gartlan et al. 2010; 
Kraft et al. 2013).
We demonstrate abundant expression of CD53 on lys-
osomes and of both tetraspanins on endosomes in human 
monocytes. The presence of tetraspanin proteins in intra-
cellular vesicles has been linked to their function to regu-
late the trafficking of their partner proteins through the 
cell (Berditchevski and Odintsova 2007; Charrin et al. 
2014). In B cells, both CD37 and CD53 can be found in 
multivesicular endosomes, called MHC class II-enriched 
compartments (Escola et al. 1998). Furthermore, it has 
been described that CD37 contains a tyrosine-based sort-
ing motif which targets this protein to endocytic vesicles 
(Berditchevski and Odintsova 2007).
The predominant expression of CD37 observed on B 
lymphocytes and in B cell follicles is in line with former 
studies reporting an important role for CD37 in B cell func-
tion (Knobeloch et al. 2000; van Spriel et al. 2009, 2012; 
Lapalombella et al. 2012). In the cytoplasmic tails of CD37, 
“ITIM-like” and “ITAM-like” motifs have been reported 
that regulate B cell death and survival, respectively (Lapa-
lombella et al. 2012). Interestingly, the dynamic process of 
B cell differentiation and selection in GCs coincides with 
lower CD37 expression toward plasma cell differentiation 
(Barrena et al. 2005). Tetraspanins play a well-established 
role in cancer development and progression (Hemler 2014), 
and CD37-directed targeted therapies are currently under 
investigation in clinical trials in patients with B cell malig-
nancies (Zhao et al. 2007; Robak et al. 2009; Rafiq et al. 
2013).
We observed primary myeloid and plasmacytoid DCs 
in human blood to express CD37 protein suggesting that 
CD37 may be involved in human DC function. This is 
supported by studies with DCs of CD37-deficient mice 
which show that CD37 promotes cell migration (Gartlan 
et al. 2013) and inhibits antigen presentation via MHC 
class II molecules (Sheng et al. 2009). T cells present in 
lymphoid organs were mostly CD37bright, which may be 
linked to the reported function of CD37 in T cell prolif-
eration, which predominantly takes place in lymphoid 
organs upon antigen presentation by DCs. T cells that 
are deficient in CD37 have disturbed regulation of T cell 
receptor signaling leading to increased proliferation (van 
Spriel et al. 2004). Remarkably, lymphocytes in various 
Fig. 6  Localization and expression of CD37 in bone marrow (a–f), 
spleen (g–l) and appendix (m–r). a, g, m Representative origi-
nal multispectral image of lymphoid organ stained for CD3 (Warp 
Red), CD37 (True Blue) and cell nuclei (Nuclear Red). Scale 
bars = 100 μm. b, h, n Composite RGB image after spectral unmix-
ing of original image (red CD3, blue CD37, green nuclei). c, i, o 
Image showing scoring of CD3−CD37dim (blue), CD3+CD37dim 
(red), CD3+CD37bright (yellow) or CD3−CD37bright (green) cells. 
Optical density of CD37 on individual cells in human bone marrow 
(d), in B cell follicle (blue line) and in T cell zone and in red pulp 
(red line) in human spleen (j) and in B cell follicle (blue line) and 
in lamina propria (red line) in human appendix (p). Optical densi-
ties were binned per 0.05 and normalized to % of max. Percentage 
of CD37dim and CD37bright cells in total bone marrow (e) and in the 
CD3+ cell population in human bone marrow (f). Percentage of total 
CD37bright cells in B cell follicle and red pulp (k) and in the CD3+ 
cell population in T cell zone and red pulp (l) in human spleen. Per-
centage of total CD37bright cells (q) and in the CD3+ cell population 
(r) in B cell follicle and lamina propria in human appendix. Each dot 
represents data of one ×20 image from the lymphoid tissue. The red 
line represents the mean. *P < 0.05, ****P < 0.0001
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Fig. 7  Localization and expression of CD53 in bone marrow (a–f), 
spleen (g–l) and appendix (m–r). a, g, m Representative original 
multispectral image of lymphoid organ stained for CD20 (Warp Red), 
CD53 (True Blue) and cell nuclei (Nuclear Red). Scale bars in a, g, 
m = 100 μm. b, h, n, Composite RGB image after spectral unmix-
ing of original image (red CD20, blue CD53, green nuclei). c, i, o, 
Image showing scoring of CD20−CD53dim (blue), CD20+CD53dim 
(red), CD20+CD53bright (yellow) or CD20−CD53bright (green) cells. 
d, j, p, Optical density of CD53 on individual cells in human bone 
marrow (d), in B cell follicle (blue line) and in T cell zone and in red 
pulp (red line) in human spleen (j) and in B cell follicle (blue line) 
and in lamina propria (red line) in human appendix (p). Optical den-
sities were binned per 0.05 and normalized to % of max. Percentage 
of CD53dim and CD53bright cells in the CD20+ cell population (e) and 
in the CD3+ cell population (f) in human bone marrow. Percentage 
of CD53bright cells in the CD20+ cell population in the B cell follicle 
and red pulp (k), and in the CD3+ cell population in the T cell zone 
and red pulp (l) in human spleen. Percentage of CD53bright cells in the 
CD20+ cell population (q) and in the CD3+ cell population (r) in the 
B cell follicle and lamina propria in human appendix. Each dot repre-
sents data of one ×20 image from the lymphoid tissue. The red line 
represents the mean. *P < 0.05, ****P < 0.0001
tissue regions within spleen and appendix often expressed 
significantly different levels of CD37 and CD53. For 
example, significantly more T cells in the red pulp were 
CD37bright compared to T cells in the T cell zone, sug-
gesting that CD37 expression correlates with immune cell 
localization though it is also possible that these represent 
different T cell subsets.
The role of CD53 in the immune system has not been 
clearly defined although a CD53-deficient family has been 
reported that suffered from recurrent infections (Mol-
linedo et al. 1997). Our study now demonstrates that CD53 
in blood is expressed on all immune cells with the high-
est expression on B cells, monocytes and mDC and pDC 
subsets. Within the secondary lymphoid tissues spleen and 
appendix, CD53 was highly expressed on both CD20+ and 
CD3+ cells. Surprisingly, we found CD20+ B lympho-
cytes in bone marrow to be mostly CD53dim which may be 
related to the finding that CD53 is under the control of the 
transcription factor early B cell factor-1 (EBF-1) (Månsson 
et al. 2007). EBF-1 is essential for B cell development by 
inducing expression of the genes encoding the (pre-)BCR, 
from which production is started in pre-B cells. CD53 has 
also been shown to interact with protein kinase C (PKC) 
(Zhang et al. 2001; personal communication), a central 
signaling molecule important in cell proliferation, differen-
tiation and apoptosis. We anticipate that CD53 may only be 
expressed during later stages of B cell development in the 
bone marrow when the (pre-)BCR is expressed, which is 
in line with an earlier study showing lower levels of CD53 
in earlier maturation stages of B cells within bone marrow 
(Barrena et al. 2005). Furthermore, we demonstrate abun-
dant CD53 expression on T cells within blood and lym-
phoid organs. Although CD53 function in T cells is largely 
unknown to date, a strong correlation between CD53 
expression on murine thymocytes and positive selection has 
been reported in the thymus (Puls et al. 2002).
In conclusion, we demonstrate the differential expres-
sion of tetraspanins CD37 and CD53 in the human immune 
system. Multispectral imaging allowed us to obtain quanti-
tative expression data that are directly linked to tissue dis-
tribution. This study offers guidance for further exploring 
tetraspanin function in the human immune system using 
this novel imaging technique.
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